JN Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 95: 1727-1734, 2006. First published November 30, 2005; doi:10.1152/jn.00771.2005
0022-3077/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/3/1727    most recent
00771.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, C. G.
Right arrow Articles by Westbrook, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, C. G.
Right arrow Articles by Westbrook, G. L.

Synaptic and Extrasynaptic NMDA Receptor NR2 Subunits in Cultured Hippocampal Neurons

Christopher G. Thomas, Ashleigh J. Miller and Gary L. Westbrook

Vollum Institute, Oregon Health and Science University, Portland, Oregon

Submitted 21 July 2005; accepted in final form 22 November 2005


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Early in development, neurons only express NR1/NR2B-containing N-methyl-D-aspartate (NMDA) receptors. Later, NR2A subunits are upregulated during a period of rapid synapse formation. This pattern is often interpreted to indicate that NR2A-containing receptors are synaptic and that NR2B-containing receptors are extrasynaptic. We re-examined this issue using whole cell recordings in cultured hippocampal neurons. As expected, the inhibition of whole cell currents by the NR2B-specific antagonist, ifenprodil, progressively decreased from 69.5 ± 2.4% [6 days in vitro (DIV)] to 54.9 ± 2.6% (8 DIV), before reaching a plateau in the second week (42.5 ± 2%, 12–19 DIV). In NR2A–/– neurons, which express only NR1/NR2B-containing NMDA receptors, autaptic excitatory postsynaptic currents (EPSCs; ≥12 DIV) were more sensitive to ifenprodil and decayed more slowly than EPSCs in wild-type neurons. Thus NR2B-containing receptors were not excluded from synapses. We blocked synaptic NMDA receptors with MK-801 during evoked transmitter release, thus allowing us to isolate extrasynaptic receptors. Ifenprodil inhibition of this extrasynaptic population was highly variable in different neurons. Furthermore, extrasynaptic receptors in autaptic cultures were only partially blocked by ifenprodil, indicating that NR2A-containing receptors are not exclusively confined to the synapse. Extrasynaptic NR2A-containing receptors were also detected in NR2A–/– neurons transfected with full-length NR2A. Truncation of the NR2A C terminus did not eliminate synaptic expression of NR2A-containing receptors. Our results indicate that NR2A- and NR2B-containing receptors can be located in either synaptic or extrasynaptic compartments.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
N-methyl-D-aspartate (NMDA) receptors are multimers of NR1/NR3 and NR2 subunits. The time- and tissue-specific expression of NR2 subunits affect channel properties as well as the distribution of NMDA receptors (Monyer et al. 1994Go). Expression of the NR2A subunit in the rodent CNS begins at 6–10 days postnatal (Monyer et al. 1994Go; Sheng et al. 1994Go; Zhong et al. 1994Go), a particularly dynamic period in synapse development. Before that point, hippocampal NMDA receptors are largely NR1/NR2B heterodimers, resulting in excitatory postsynaptic currents (EPSCs) that slowly deactivate and are strongly inhibited by NR2B-specific antagonists such as ifenprodil (Flint et al. 1997Go; Kew et al. 1998Go; Kirson and Yaari 1996Go; Li et al. 1998Go; Tovar and Westbrook 1999Go). NR2A can be incorporated into several subunit combinations including NR1/NR2A heterodimers and NR1/NR2A/NR2B heterotrimers, resulting in a developmental reduction in NR2B-specific antagonist sensitivity as well as an acceleration of the deactivation of NMDA receptor-mediated EPSCs. (Flint et al. 1997Go; Kew et al. 1998Go; Kirson and Yaari 1996Go; Li et al. 1998Go; Tovar and Westbrook 1999Go). Although NR2A subunits clearly contribute to synaptic NMDA receptors, the existing data do not completely support the idea that NR2A-containing receptors are exclusively synaptic and NR2B-containing receptors are exclusively extrasynaptic (Mohrmann et al. 2000Go; Stocca and Vicini 1998Go; Tovar et al. 2000Go; Townsend et al. 2003Go).

Recent experiments suggest that synaptic and extrasynaptic receptors may have distinct roles in synaptic plasticity, coupling to intracellular signaling cascades, and cell death (Hardingham et al. 2002Go; Liu et al. 2004Go; Massey et al. 2004Go). During synaptic development, NMDA receptors become clustered at synapses, but a population of extrasynaptic receptors remains (Cottrell et al. 2000Go; Pickard et al. 2000Go; Rosenmund et al. 1995Go). Synaptic clustering of NMDA receptors is in part controlled by intracellular protein–protein interactions with postsynaptic density proteins (Bolton et al. 2000Go; Scannevin and Huganir 2000Go). The sequence of trafficking, targeting, and anchoring of NMDA receptors remains an active area of investigation (Perez-Otano and Ehlers 2004Go; Wenthold et al. 2003Go). The underlying mechanisms for localization and signaling may involve differential binding of proteins to the cytoplasmic domains of NR2A and NR2B (Guillaud et al. 2003Go; Lavezzari et al. 2004Go; Sans et al. 2000Go).

We used whole cell recordings in cultured hippocampal neurons to determine the NR2 subunit composition of synaptic and extrasynaptic receptors during development in vitro. We confirmed that NR2A-containing receptors are incorporated into synapses during development. However, the extrasynaptic population included both NR2B- and NR2A-containing receptors. Transfection of an NR2A C-terminal truncation mutant subunit into neurons from NR2A–/– mice showed that the cytoplasmic domain was not essential for synaptic localization.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Cell culture

Cell cultures were prepared from hippocampi of newborn wild-type or NR2A–/– mice. As previously described (Jahr and Stevens 1987Go), hippocampi were removed, incubated with papain (Worthington, Lakewood, NJ), and mechanically dissociated. Neurons (150,000 cells/dish = 300 cells/mm2) were plated onto a confluent layer of glia on glass coverslips (Fisher, Pittsburgh, PA). For single neuron (autaptic) cultures, cells (50,000 cells/dish = 100 cells/mm2) were plated onto glial microislands. Hippocampal glia were grown to confluency on coverslips (25 mm) coated with collagen (Cohesion, Palo Alto, CA) and poly-L-lysine (Sigma, St. Louis, MO). For autapses, coverslips were coated with 0.15% agarose (Sigma) and sprayed with a mixture of collagen, poly-D-lysine (BD Biosciences, Bedford, MA) and 17 mM acetic acid (Bekkers and Stevens 1991Go). For some experiments, 100 µM AP5 (Tocris, Ellisville, MO) was added to the culture medium from 4 to 6 DIV.

GENOTYPING NR2A–/– mice were bred on a C57BL/6 wild-type background and genotyped using PCR amplification of genomic DNA. As previously described (Tovar et al. 2000Go), tissue was incubated in proteinase K (0.5 mg/ml; Gibco BRL, Carlsbad, CA) at 55°C for ≥12 h. Samples were centrifuged, and genomic DNA was precipitated from supernatants by adding an equal volume of isopropanol. The precipitated DNA was pelleted by centrifugation, washed in ice cold 70% ethanol, and allowed to dry. Genomic DNA was resuspended in TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) and added to the following PCR mixture: Mg2+ (2.15 mM), dNTPs (0.2 mM each), oligonucleotide primers (0.01 mg/ml each), Taq polymerase (2.5 units; Promega, Madison, WI), reaction buffer (5 µl), and 2 µl of solubilized genomic DNA (50 µl final volume) in high-performance liquid chromatography (HPLC) water. Two reactions were performed on each DNA sample. The first reaction used: primer 1, 5'-TCTGGGGCCTGGTCTTCAACAATTCTGTGC –3'; primer 2, 5'-CCCGTTAGCCCGTTGAGTCACCCCT-3', and the Neo Primer, 5'-GCCTGCTTGCCGAATATCATGGTGGAAAAT-3'. The second reaction used primer 1, the Neo Primer, and primer 3: 5'-ATTCTTTGATAAATGCAATGATGGGGG-3'. Reaction products were run on 2% agarose gels and visualized using ethidium bromide. In the first set of reactions, DNA from NR2A–/– mice yielded 1,553- and 418-bp products, whereas DNA from wild-type mice yielded a single 180-bp product. The 418-bp product represented the neop1 gene insert. In the second set of reactions, DNA from NR2A–/– mice yielded 1,620 and 485 (neo1p insert)-bp products, whereas DNA from wild-type mice yielded a single 253-bp product. Gel purification and sequencing of the reaction products yielded the expected DNA sequences (data not shown).

TRANSFECTION We transfected cell cultures at 6 DIV using the lipid-based Effectene kit (Qiagen USA, Valencia, CA). For most experiments, cultures were incubated in serum free media for 2 h before the reaction solution containing 0.5 µg of full-length NR2A or the truncation mutant (NR2Astop844) subunit plasmid cDNA and 0.5 µg of enhanced green fluorescent protein (EGFP) plasmid cDNA was added to each culture. Transfections were stopped after 90 min by replacing the media with serum containing media. Recordings from transfected neurons were made 1–3 days after transfection (7–9 DIV). For imaging, 0.5 µg of EGFP-tagged NR2A (GFP-NR2A) was co-transfected with 0.5 µg of carrier DNA (Gibco-BRL). NR2A, NR2Astop844, and GFP-NR2A cDNA were inserted into pcDNA1/AMP provided by Stephen Heinemann (Salk Institute, La Jolla, CA). The EGFP construct was inserted into the JPA7 vector provided by Gary Banker (CROET, OHSU, Portland, OR).

ELECTROPHYSIOLOGY Whole cell voltage-clamp recordings were made at a holding potential of –70 mV. The superfused extracellular bath solution contained (in mM) 162 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 1 CaCl2, 0.0005 TTX (Alomone Labs, Jerusalem, Israel), 0.01 bicuculline methiodide (Sigma), 0.002 strychnine (Sigma), and 0.1 glycine, pH 7.2, 320 mOsm. For autapses, TTX was omitted, and calcium was increased to 2 mM. Patch pipettes (2–5 M{Omega}) were filled with (in mM) 145 Cs-gluconate, 1 MgCl2, 10 HEPES, 1.1 EGTA, and 5 CsBAPTA, pH 7.2, 310 mOsm. For autapses, we used (in mM) 150 K-gluconate, 1.418 CaCl2, 2 MgCl2, 10 EGTA, 10 HEPES, 2 Na2ATP, and 0.2 GTP, pH 7.2, 310 mOsm. Quartz flow pipes for solution exchanges were placed 50–100 µm from the cell and mounted to a piezoelectric bimorph driven by a stimulus isolation unit (Winston Electronics, San Francisco, CA). Step depolarizations (+10 mV, 0.5 ms) were used to evoke autaptic EPSCs. Currents were recorded using an Axopatch 1C (Axon Instruments, Foster City, CA) amplifier and Axograph acquisition software. Currents were filtered at 2 kHz and digitized at 5 kHz.

IMMUNOFLUORESCENCE Four days after transfection, GFP-NR2A-transfected NR2A–/– neurons (10 DIV) were live stained (anti-GFP, rabbit, Molecular Probes, Eugene, OR, 1:200) in serum-free medium for 5 min at 37°C. Neurons were washed in PBS solution containing 1 mM MgCl2 and 0.1 mM CaCl2 and fixed in 4% paraformaldehyde and 4% sucrose in PBS for 20 min at 37°C. Cells were permeabilized in 0.3% Triton-X-100 in PBS for 5 min, blocked in 0.5% fish gelatin in PBS for 30 min, incubated in primary antibody (anti-Synapsin 1, mouse, Synaptic Systems, Goettingen, Germany, 1:500 in blocking solution) for 2–3 h and then in secondary antibodies (goat anti-mouse Alexa A633, Molecular Probes, 1:1000 and biotinylated goat anti-rabbit, Jackson ImmunoResearch Laboratories, West Grove, PA, 1:1000 in blocking solution) for 30 min, and finally incubated in Cy3 streptavidin (Jackson, 1:10,000, in blocking solution) for 30 min. All steps excluding live staining and fixation were performed at room temperature. A Leica DM-RXA (Bannockburn, IL) microscope equipped with a x63, 132 NA. Plan Apo objective and a Princeton Instruments Micromax (Trenton, NJ) CCD camera were used for immunofluorescense imaging of stained neurons. Digital images were acquired and pseudocolored with MetaMorph (Universal Imaging, Buckinghamshire, UK) imaging software and prepared for presentation with Adobe Photoshop (San Jose, CA).

DATA ANALYSIS Currents were analyzed with Axograph software (Axon Instruments). Ifenprodil inhibition was expressed as percent inhibition of the peak NMDA receptor–mediated current [1 – (INMDA+Ifenprodil/INMDA) x 100. Miniature EPSC recordings were analyzed with a variable template function. The template was set up to detect AMPA receptor–mediated events that were five to six times greater than the SD of the background noise. Each event was verified by eye and averaged with a minimum of 50 events per recording condition. Autaptic EPSCs and mEPSCs were averaged for each drug condition. Ifenprodil inhibition of EPSCs was expressed as percent inhibition of the NMDA receptor–mediated component, measured 10–20 ms after the beginning of an event. The decay of NMDA receptor–mediated autaptic EPSCs, recorded in the presence of NBQX, was fit with the sum of two exponentials and presented as a weighted average decay. The larger amplitude of EPSCs at 12–19 DIV allowed a more accurate estimate of the slow time constant than in our earlier studies on neurons at 6 DIV (Tovar and Westbrook 1999Go). Pooled data are presented as means ± SE. For statistical comparisons, paired and unpaired t-tests or ANOVAs with subsequent Bonferroni/Dunn test for multiple comparisons were used as appropriate. Statistical significance was set at P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
NR2A subunits are incorporated into NMDA receptors during synaptic maturation in vitro

We used the noncompetitive, NR2B-selective inhibitor, ifenprodil, to examine the contribution of NR2A and NR2B subunits to whole cell and synaptic currents. At a concentration of 3 µM, ifenprodil blocked 73.8 ± 2.4% of whole cell NMDA-induced currents recorded in hippocampal neurons from NR2A–/– mice (n = 14, Fig. 1, A and B) that only express NR1/N2B heterodimeric NMDA receptors. This concentration of ifenprodil is the highest that can be used without affecting NR2A-containing receptors, and the degree of block we observed is consistent with block of NR1/2B recombinant receptors (Tovar and Westbrook 1999Go). NR2A expression develops as synaptic activity gradually increases during the first week in vitro (Monyer et al. 1994Go; Sheng et al. 1994Go). Thus to synchronize NR2A expression (Chavis and Westbrook 2001Go; Hoffmann et al. 2000Go), we blocked synaptic activity with AP5 (100 µM) between days 4 and 6 in vitro. Ifenprodil inhibited 69.5 ± 2.4% (n = 25) of the whole cell current recorded in wild-type neurons at 6 DIV, consistent with prior evidence that early in development NMDA receptors are primarily NR1/NR2B heteromers. The slightly higher ifenprodil inhibition in NR2A–/– neurons than in wild-type neurons at 6 DIV presumably reflects a small amount of NR2A expression triggered by residual synaptic activity between days 4 and 6. Ifenprodil inhibition decreased from 61.4 ± 2% (n = 29) at 7 DIV and 54.9 ± 2.6% (n = 26) at 8 DIV to 42.5 ± 2% (n = 21) in synaptically mature neurons (12–19 DIV). This is consistent with an increase in NR2A-containing receptors, but also indicates that both NR2A- and NR2B-containing receptors contribute to the whole cell current even in synaptically mature cells.


Figure 1
View larger version (19K):
[in this window]
[in a new window]
 
FIG. 1. NR2A subunits are incorporated into N-methyl-D-aspartate (NMDA) receptors during synaptic maturation in vitro. A: we recorded responses to 500-ms whole cell applications of NMDA (100 µM) or NMDA and ifenprodil (3 µM) from NR2A–/– (left) and wild-type neurons at 6 (middle) and ≥12 DIV (right). Wild-type neurons were pretreated with AP5 (100 µM) for 48 h between 4 and 6 DIV to reduce NR2A expression. As a result, ifenprodil inhibition of wild-type neurons at 6 DIV was similar to that of NR2A–/– neurons that express only NR1/NR2B NMDA receptors. B: ifenprodil inhibition of neurons progressively declined because of increased NR2A expression, but reached a plateau between 12 and 19 days in vitro (DIV) (NR2A–/–, n = 16; wild-type 6 DIV, n = 21; 7 DIV, n = 29; 8 DIV, n = 26; 12–19 DIV, n = 21; ANOVA with Bonferroni post hoc test, P < 0.01; *different from NR2A–/–; {dagger}different from 6 DIV wild-type). C: autaptic excitatory postsynaptic currents (EPSCs) from synaptically mature (≥12 DIV) NR2A–/– (left) and wild-type (right) neurons were recorded in control solution and after perfusion with AP5 (100 µM) or ifenprodil (3 µM). The slow component was blocked by AP5. EPSCs in wild-type neurons were less inhibited by ifenprodil than in NR2A–/– neurons, indicating that NR2A subunits are incorporated into synaptic NMDA receptors. D: normalized average NMDA receptor–mediated autaptic EPSCs recorded from mature NR2A–/– and wild-type neurons in the presence of 5 µM 6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione (NBQX). Decay currents were fitted with the sum of 2 exponentials. The weighted average of time constants for the wild-type EPSCs decayed significantly faster (435 ms, n = 6) than NR2A–/– EPSCs (723 ms, n = 4).

 
Whole cell currents include both synaptic and extrasynaptic components. To examine synaptic NMDA receptors, we evoked EPSCs in autaptic cultures. EPSCs in wild-type (12–19 DIV) and NR2A–/– neurons (12–19 DIV) had a fast AMPA receptor component followed by an AP5-sensitive NMDA receptor component (Fig. 1C). Ifenprodil blocked 86.5 ± 5.7% (n = 4) of NR2A–/– EPSCs, showing that NR1/2B receptors can be located at synapses after synaptic maturation. Ifenprodil inhibition was partial in wild-type neurons (55.8 ± 9.9%, n = 5), indicating NR2B-containing receptors are also present at wild-type synapses. NR1/2B receptors have much slower deactivations than NR1/2A receptors (Vicini et al. 1998Go). Thus as expected, NMDA receptor–mediated EPSCs in wild-type neurons decayed significantly faster (435 ± 31 ms, n = 6) than in NR2A–/– neurons (723 ± 64 ms, n = 4; Fig. 1D). The deactivation reported in wild-type neurons was somewhat slower than in immature cultured neurons (~300 ms; Tovar and Westbrook 1999Go), probably reflecting the better signal-to-noise ratio in more mature neurons. The deactivation of wild-type EPSCs was also much slower than NR1/2A EPSCs recorded in NR2B–/– hippocampal autapses (Tovar et al. 2000Go). This was not a result of separate populations of pure NR1/2A and NR1/2B receptors at wild-type synapses because the deactivation was similar before and after ifenprodil (Fig. 1C, right). Rather, it suggests that there is a substantial contribution of triheteromeric receptors to wild-type EPSCs.

Isolation of extrasynaptic NMDA receptors

It is difficult to separate synaptic and extrasynaptic receptors in most preparations. However, extrasynaptic NMDA receptors can be studied in isolation in autapses by first irreversibly blocking synaptic NMDA receptors with MK-801 (Rosenmund et al. 1995Go). We developed an analogous protocol using high potassium–evoked release of glutamate to block synaptic NMDA receptors in multi-cell cultures. We first measured the whole cell NMDA current (Fig. 2A, left). Then the cell was treated with a series of 10 or more whole cell applications (500 ms) of potassium (90 mM), calcium (6 mM), and MK-801 (60 µM) in the presence of NBQX (5 µM) until the current reached a plateau (Fig. 2A, middle). The residual current after 10 applications represented inward potassium current induced by the 90 mM K+ solution. Subsequent application of NMDA revealed that the treatment irreversibly blocked 71 ± 3% (n = 12) of the NMDA current. Substitution of AP5 (100 µM) for MK-801 did not reduce subsequent whole cell NMDA currents (4.7 ± 3.1%, n = 4), indicating that potassium treatment itself did not affect the NMDA current. The fraction of remaining NMDA current was similar to the extrasynaptic fraction previously reported in autapses (Rosenmund et al. 1995Go).


Figure 2
View larger version (20K):
[in this window]
[in a new window]
 
FIG. 2. MK-801 blocked synaptic NMDA receptors during potassium-induced release. A: whole cell NMDA receptor responses recorded from a synaptically mature wild-type neuron before (left) and after (right) repeated applications of a high K+/MK-801 solution (90 mM K+, 60 µM MK-801, 6 mM CaCl2, 5 µM NBQX, middle). MK-801 block reduced the whole cell NMDA receptor current in this neuron by 80%. The time-independent residual current after the 15th application reflects inward K+ leak current in the presence of 90 mM K+. B: miniature EPSCs (mEPSCs) recorded from a wild-type neuron in control (top) or AP5 (100 µM, bottom), before (left) and after (right) the synaptic block protocol. C: ensemble average mEPSCs from the cell shown in B had a slow-decaying, AP5-sensitive component (left) that was blocked by the high K+/MK-801 treatment (right). D: left: NMDA receptor amplitudes, measured over a 10- to 20-ms interval of the ensemble mEPSC were eliminated by synaptic block with MK-801 (paired t-test, P < 0.005). However, the synaptic block protocol had no effect on the amplitude or the frequency of the AMPA receptor component of mEPSCs recorded in the presence of AP5 (n = 7).

 
We recorded mEPSCs before and after MK-801 block to confirm that the protocol blocked all synaptic NMDA receptors (Fig. 2B). The ensemble average mEPSC before MK-801 had an NMDA receptor–mediated component that was blocked by AP5 (Fig. 2C, left). However, the NMDA receptor component was no longer present after MK-801 block (Fig. 2C, right; n = 6). The treatment protocol did not change the amplitude of the AMPA receptor–mediated mEPSCs or the frequency of events, suggesting that transmitter release was unaffected (Fig. 2D). Autaptic EPSCs, recorded before and after MK-801 also showed that the treatment protocol blocked synaptic NMDA receptors (data not shown). Thus the NMDA current remaining after MK-801 is only mediated by extrasynaptic receptors. We used this strategy to study the distribution of NR2A- and NR2B-containing receptors.

NR2A is present in extrasynaptic NMDA receptors

If NR2A-containing receptors are synaptic and NR2B-containing receptors are extrasynaptic, the extrasynaptic population should be highly sensitive to ifenprodil. To follow the distribution of newly expressed NR2A subunits during maturation, we measured ifenprodil inhibition of NMDA receptor currents before and after MK-801 treatment. As seen in Fig. 1, ifenprodil inhibition of total whole cell current, including both synaptic and extrasynaptic receptors, was less in synaptically mature neurons (43.4 ± 2.6%, n = 14) than at 6 DIV (64.4 ± 3.6%, n = 12; Fig. 3A, left). The ifenprodil inhibition of the extrasynaptic population as measured after MK-801 treatment (Fig. 3A, right) was highly variable between neurons. At 6 DIV, the ifenprodil inhibition of the extrasynaptic population was 63.8 ± 3.8% (range, 39–83%, n = 12; Fig. 3A, top right). In synaptically mature neurons, the ifenprodil inhibition was 49.1 ± 3.5% (range, 19–61%, n = 13), which was marginally greater than that for the total whole cell current (Fig. 3A, bottom). The variability in ifenprodil inhibition of the extrasynaptic population suggested that, at least in some cells, NR2A-containing receptors were extrasynaptic. Consistent with this idea, the total and extrasynaptic population of NMDA receptors in mature autapses showed similar ifenprodil inhibition (Fig. 3B). Before MK-801, the inhibition was 42.5 ± 6.9% (n = 4) compared with 37.5 ± 5.5% (n = 4) after blocking synaptic NMDA receptors. Furthermore, in inhibitory neuron autapses that lack any synaptic NMDA receptors, ifenprodil inhibition of this purely extrasynaptic population was 40.1 ± 5.1% (n = 9). Thus under several different experimental conditions, the ifenprodil sensitivity of the extrasynaptic population was less than predicted for NR1/NR2B receptors.


Figure 3
View larger version (23K):
[in this window]
[in a new window]
 
FIG. 3. Ifenprodil inhibition of extrasynaptic NMDA receptors was variable. A: representative traces of whole cell responses to NMDA (100 µM) or NMDA and ifenprodil (3 µM) recorded before (left) and after (right) blocking synaptic receptors with high K+/MK-801 from 6 DIV (top) and synaptically mature (bottom) wild-type neurons that had been chronically treated with AP5 (100 µM) for 48 h between 4 and 6 DIV. Dashed lines compare ifenprodil inhibition before and after blocking with MK-801. B: ifenprodil inhibition was recorded in synaptically mature autapses before (left) and after (right) blocking synaptic receptors with MK-801 during action potential–evoked transmitter release. The ifenprodil inhibition of extrasynaptic receptors (top right) in 6 DIV cells was similar to inhibition of the total population of receptors recorded before MK-801 block (top left). In contrast, the ifenprodil inhibition of extrasynaptic receptors recorded in synaptically mature neurons varied regardless of the way transmitter release was evoked during MK-801 block, indicating that extrasynaptic receptors may contain NR2A subunits.

 
Transfected NR2A is incorporated into synaptic NMDA receptors of NR2A–/– neurons

The intracellular domains of NMDA receptors subunits contain protein interacting domains that are thought to influence their targeting, location, and function (Perez-Otano and Ehlers 2004Go; Wenthold et al. 2003Go). To examine the role of the cytoplasmic domain of NR2A in synaptic localization, we used NR2A–/– neurons as a background into which we introduced full-length or mutant recombinant NR2A subunits. We transfected NR2A–/– cultured neurons at 6 DIV with an N-terminally, EGFP-labeled NR2A (GFP-NR2A) subunit. Four days later (10 DIV), the neurons were live-immunostained for GFP, fixed, permeabilized, and immunostained for synaptophysin. Puncta representing cell-surface GFP-NR2A were scattered throughout the dendrites (Fig. 4A, red pseudocolor). In these cultures containing both excitatory and inhibitory neurons, the presynaptic marker synaptophysin identified synapses, some of which were co-localized with GFP-NR2A (Fig. 4A). These results suggest that transfected NR2A subunits were functionally expressed at synapses.


Figure 4
View larger version (40K):
[in this window]
[in a new window]
 
FIG. 4. Exogenous NR2A subunits are incorporated into synaptic NMDA receptors of transfected NR2A–/– neurons. A1 and A2: dendrites from 2 different NR2A–/– neurons (10 DIV) that were transfected at 6 DIV with N-terminally green fluorescent protein (GFP)-labeled NR2A cDNA (GFP-NR2A), live-stained with an anti-GFP antibody (red), fixed, permeabilized, and counterstained with an anti-synapsin antibody (green). Arrows indicate examples of co-localization of cell-surface GFP-NR2A with synapsin. In each cell there were more GFP than anti-GFP puncta, suggesting that GFP-NR2A subunits were located both on the cell surface and in the cytoplasm (data not shown). B: ensemble average mEPSCs recorded in the presence of control solution (black), AP5 (100 µM, blue), and ifenprodil (3 µM, red) from a 15 DIV wild-type neuron (left), a 12 DIV NR2A–/– neuron (middle), and a 14 DIV NR2A–/– neuron transfected with NR2A at 6 DIV (right). Dashed lines indicate the 10–20 ms where NMDA receptor amplitudes were measured. Ifenprodil inhibition of the NR2A-transfected NR2A–/– neuron (57% inhibition) was less than that seen for the NR2A–/– neuron (82%) and similar to that for the wild-type neuron (34%).

 
To examine the synaptic receptors in the transfected neurons, we recorded mEPSCs in cells that had been transfected with full-length NR2A subunit cDNA. GFP-NR2A has low fluorescent intensity, thus we co-transfected the neurons with EGFP as a screen. Ensemble average mEPSCs from mature wild-type (12–19 DIV), mature untransfected NR2A–/– (12–19 DIV), and NR2A-transfected NR2A–/– (7–14 DIV) neurons all had fast AMPA receptor–mediated components followed by a slow NMDA receptor–mediated component (Fig. 4B). In each case, the slow component was completely blocked by AP5. The NR1/2B receptors of the NR2A–/– mEPSCs were more inhibited by ifenprodil (71.8 ± 6.2%, n = 8 cells) than either wild-type neurons (57.3 ± 8.3%, n = 6 cells) or NR2A–/– neurons transfected with NR2A (24.1 ± 12.3%, n = 4). Thus transfected full-length NR2A subunits were successfully incorporated into functional synaptic NMDA receptors.

NR2A subunits lacking the cytoplasmic domain can be located at synapses

Steigerwald et al. (2000)Go reported that mice expressing a C-terminal truncation mutant of NR2A have less synaptic NMDA receptors. We tested the role of the NR2A C terminus using cultured NR2A–/– neurons transfected with either a full-length NR2A or a C-terminal truncation mutant, NR2Astop844 (Fig. 5). Using the protocol shown in Fig. 3, we measured ifenprodil inhibition of the total whole cell NMDA current and the isolated extrasynaptic component. Compared with ifenprodil inhibition of untransfected NR2A–/– neurons (73.79 ± 2.4%, n = 14), expression of either NR2A subunit significantly reduced inhibition both before and after MK-801 treatment. For neurons transfected with full-length NR2A ifenprodil inhibition was 32.8 ± 5.9%, (n = 9) before MK-801 treatment and 24.4 ± 5.6%, (n = 9) after the treatment. For neurons transfected with NR2Astop844, ifenprodil inhibition was 56.2 ± 4.3% (n = 12) before MK-801 treatment and 53.9 ± 3.8% (n = 12) after the treatment. There was no effect on the average amplitude of the whole cell current (NR2A–/–, 4.2 ± 1.1 nA, n = 14; NR2A–/– + NR2A, 6.6 ± 0.9 nA, n = 9; NR2A–/– + NR2Astop844, 6.6 ± 1.2 nA, n = 12). Thus transfected NR2A subunits lacking the C-terminal domain can be incorporated into synaptic as well as extrasynaptic NMDA receptors. Consistent with this idea, ifenprodil inhibition of the ensemble average mEPSC from NR2A–/– neurons transfected with NR2Astop844 was 22.0 ± 5.9% (n = 7), similar to mEPSCs in neurons transfected with full-length NR2A.


Figure 5
View larger version (21K):
[in this window]
[in a new window]
 
FIG. 5. C-terminally truncated NR2A subunits are present in synaptic receptors of transfected NR2A–/– neurons. A: neurons (7–9 DIV) from NR2A–/– mice were transfected at 6 DIV with either full-length NR2A (top) or the C-terminal truncation mutant, NR2Astop844 (bottom). Representative traces of whole cell responses to NMDA (100 µM) or NMDA and ifenprodil (3 µM) recorded before (left) and after (right) blocking synaptic receptors with high K+/MK-801. B: average ifenprodil inhibitions recorded, pairwise, before (black panels) and after (gray panels) MK-801 block from the transfected NR2A–/– neurons shown in A. Transfection of both types of subunits significantly reduced the ifenprodil inhibition of NR2A–/– neurons (data not shown). The ifenprodil inhibition of extrasynaptic receptors (right) from NR2Astop844-transfected cells was the same as the total population (left), consistent with the presence of the subunit in synaptic and extrasynaptic receptors. Ifenprodil inhibited currents from NR2Astop844-transfected neurons more than it did for those transfected with full-length NR2A, indicating that the truncation mutant was not incorporated into functional NMDA receptors as much as the full-length subunit. Data represents averages ± SE (NR2A–/– + NR2A, n = 9; NR2A–/– + NR2Astop844, n = 12; ANOVA with Bonferroni/Dunn post hoc test P < 0.01, {dagger}different from NR2A–/– + NR2A before synaptic block; paired t-test P < 0.05, *different from before synaptic block).

 
Although the NR2A C-terminal truncation mutant was expressed at synapses, the surface expression of this construct appeared to be less than the full-length construct because whole cell currents in NR2Astop844-transfected neurons were significantly more sensitive to ifenprodil than those transfected with full-length NR2A. The vector for both constructs was the same, suggesting that truncation of the C terminus affects receptor trafficking.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We re-examined the NR2 subunit composition of synaptic and extrasynaptic NMDA receptors using cultured hippocampal neurons. Our results suggest that NR2A- and NR2B-containing receptors are not exclusively segregated into synaptic and extrasynaptic compartments. This conclusion was supported by analysis of the extrasynaptic complement of NMDA receptors in whole cell currents, analysis of miniature and evoked EPSCs, and transfection of NR2A constructs into NR2A–/– neurons.

Validity of our approach

Our analysis relied on comparing the ifenprodil inhibition of whole cell NMDA receptor currents before and after irreversible block of synaptic receptors with MK-801. The existence of triheteromeric receptors containing NR2A and NR2B (Sheng et al. 1994Go; Tovar and Westbrook 1999Go) complicates the analysis of NMDA receptor subunit composition based on selective NR2A and NR2B antagonists. We used ifenprodil because it has been characterized on NR1/2B as well as NR1/2A/2B receptors and involves binding of the antagonist to two NR2B subunits for full inhibition (Hatton and Paoletti 2005Go; Kew et al. 1998Go; Tovar and Westbrook 1999Go). Even on NR1/2B receptors, ifenprodil at selective concentrations only blocks ~75–80% of NR1/2B current because of its noncompetitive kinetics. Using this degree of block as a reference, most whole cell current or EPSCs in mature hippocampal neurons are partially inhibited by ifenprodil (Tovar and Westbrook 1999Go) reflecting the contribution of NR2A-containing receptors. Another complication with the use of ifenprodil is that it increases receptor affinity for glutamate (Kew et al., 1996Go). Thus at low glutamate concentrations, ifenprodil can potentiate NMDA responses. We avoided this issue by using high agonist concentrations.

It is also essential to our analysis that we were able to isolate a pure population of extrasynaptic receptors. For whole cell recording, we used a modified protocol based on irreversible block of synaptic NMDA receptors by MK-801 after evoked release (Rosenmund et al. 1995Go). The protocol we used eliminated the NMDA receptor component of mEPSCs as well as the evoked EPSC in autaptic neurons without affecting transmitter release, confirming that the remaining whole cell NMDA responses were exclusively mediated by extrasynaptic NMDA receptors. The high potassium stimulation could have resulted in some spillover to extrasynaptic receptors, but this would not affect our interpretations of the remaining extrasynaptic receptor current. The high potassium stimulation might also have led to activation of "perisynaptic" receptors that could affect the analysis if this hypothetical population of receptors has a distinct NMDA receptor subunit composition.

We used transfection of NR2A constructs into NR2A–/– neurons to examine whether the cytoplasmic domain was essential for the presence of NR2A-containing receptors at synapses. Inappropriate localization caused by overexpression is always a concern with such experiments. However, the surface expression of NMDA receptors is limited by endogenous NR1, and the whole cell current amplitudes were not increased in transfected neurons. In fact, the surface expression of the truncation mutant was less than the full-length construct. Thus it seems unlikely that overexpression was the reason that NR2A subunits lacking cytoplasmic domains were present in synapses. We cannot exclude that receptors containing some exogenous NR2 subunits were inappropriately expressed in extrasynaptic locations. However, NR2A-containing receptors were also present in extrasynaptic receptors of wild-type neurons.

Distribution of NR2-containing receptors

Our results are consistent with some aspects of prior studies on NMDA receptor subunit distribution, but not with others. Specifically, the expression of both synaptic and extrasynaptic receptors early in cell culture consisted of NR1/2B receptors (Li et al. 1998Go; Tovar and Westbrook 1999Go). Also consistent with prior data, NR2A-containing receptors appeared soon after synapse formation and contributed to synaptic responses. However, the consensus across studies breaks down over whether NR2B-containing receptors are expressed at synapses and whether NR2A-containing receptors are expressed in extrasynaptic locations. Both of these occurred in our experiments. These discrepancies may be caused by difficulties in isolating extrasynaptic receptors and an underappreciation of triheteromeric receptors. However, we cannot exclude that there may also be differences based on cell types or preparations. It is perhaps not surprising that NR2B-containing receptors are expressed at synapses in NR2A–/– neurons, an effect that could be attributed to compensation. However, miniature NMDA receptor–mediated EPSCs disappear during development in collicular neurons (Townsend et al. 2003Go), suggesting that compensation does not occur in that preparation. There is strong evidence that NR2B subunits contribute to triheteromeric synaptic receptors in wild-type neurons (Kew et al. 1998Go; Luo et al. 1997Go; Sheng et al. 1994Go; Tovar and Westbrook 1999Go). However, triheteromeric receptors, which are partially sensitive to NR2B-selective antagonists, have not been seen in all cases (Stocca and Vicini 1998Go).

In occipital cortex cultures, Mohrmann et al. (2000)Go reported the presence of extrasynaptic NR2A-containing receptors, whereas such receptors were not detectable in initial studies of mature autapic hippocampal cultures (Tovar and Westbrook 1999Go). The expression of NR2A-containing receptors in the extrasynaptic population was quite variable between cells. Although the latter result suggests that NR2A receptors are not exclusively synaptic, it also suggests that their presence may be regulated. There are several possible explanations for these apparent discrepancies including differences in the developmental stage of the neurons or neuron-specific expression patterns depending on the presynaptic inputs (Gottmann et al. 1997Go; Ito et al. 2000Go).

NR2A intracellular C-terminal domain

The intracellular domains of ionotropic glutamate receptor subunits provide binding motifs for many interacting proteins that function in the trafficking and signaling of receptor complexes (Wenthold et al. 2003Go). Interactions between the C-terminal domains of NMDA receptor subunits and intracellular proteins are thought to control the synaptic and extrasynaptic localization of NMDA receptors (Perez-Otano and Ehlers 2004Go). The intracellular domains of NR2A and NR2B can differentially interact with proteins involved in trafficking and anchoring, thus providing a potential mechanism for differential distribution of NR2A- and NR2B-containing receptors (Wenthold et al. 2003Go). Consistent with an important role of the NR2A cytoplasmic domain in synaptic localization, Steigerwald et al. (2000)Go reported smaller NMDA receptor–mediated EPSCs and less clustering of receptors at synapses in hippocampal neurons from transgenic mice expressing an NR2A truncation mutant. However, they also noted an overall decrease in total NR2A expression.

Given this evidence, it was somewhat surprising to us that truncated NR2A subunits were present in synaptic NMDA receptors of transfected NR2A–/– neurons. NMDA current amplitudes in transfected neurons were not increased compared with wild-type neurons, suggesting that overexpression did not cause inappropriate targeting to the synapse. Prybylowski et al. (2002)Go also did not see increased synaptic current when NR2A was overexpressed in wild-type cerebellar granule cells. Our results by no means eliminate the possibility that the intracellular domain of NR2 subunits influences targeting because both NR1 and NR2B subunits were intact and therefore NR1/NR2A heterodimeric or NR1/N2A/NR2B heterotrimeric receptors could be compensatory.

Perhaps more interestingly, truncation of the cytoplasmic domain reduced the surface expression of NR2A-containing receptors as also was observed by Steigerwald et al. (2000)Go. This suggests that the cytoplasmic domain is important in receptor trafficking. For example, elimination of the PDZ binding motif, which occupies the last four amino acids (ESDV) of the NR2A and NR2B C termini (Kim and Sheng 2004Go), reduces the contribution of NR2A and NR2B to synaptic NMDA receptors (Barria and Malinow 2002Go). In addition, NR2A and NR2B may be trafficked differently (Guillaud et al. 2003Go; Lavezzari et al. 2004Go; Sans et al. 2000Go).

NR2A, NR2B, synaptic, and extrasynaptic

The categorization of NR2A-containing receptors as synaptic and NR2B-containing receptors as extrasynaptic has taken on additional significance because extrasynaptic receptors seem to have important functions. For example, extrasynaptic receptors have been reported to influence synaptic plasticity (Massey et al. 2004Go) and neuronal cell death (Hardingham et al. 2002Go). It has also been suggested that NR2A-containing receptors are required for long-term potentiation (Liu et al. 2004Go; Massey et al. 2004Go), whereas two recent studies have come to different conclusions (Berberich et al. 2005Go; Weitlauf et al. 2005Go). These potential distinctions between synaptic and extrasynaptic receptors may involve not only different access to released glutamate but also different intracellular signaling cascades. Our results indicate that the segregation of NR2A and NR2B is not absolute. Although the NR2-selective antagonists are handy tools, they cannot always be equated with selective block of synaptic or extrasynaptic receptors. Thus separation of these receptor populations using methods such as MK-801 block may be preferable.


    GRANTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by National Institute of Mental Health Grant MH-46613 to G. L. Westbrook.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We thank L. Grimes, F. Davis, and R. Mouton for preparation of hippocampal cell cultures, Dr. Masayoshi Mishina for the NR2A–/– mouse, Drs. Bryce Vissel and Stephen Heinemann for NMDA receptor clones, Dr. Stephanie Kaech, Dr. Michael A. Silverman, Dr. Gary Banker, S. Das, and G. Glover for the EGFP clone and for advice with immunocytochemistry, and Drs. Johannes J. Krupp and Kenneth R. Tovar for useful comments.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests and other correspondence: G. L. Westbrook, Vollum Inst., OHSU L474, 3181 SW Sam Jackson Park Rd., Portland, OR 97239 (E-mail: westbroo{at}ohsu.edu)


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Barria A and Malinow R. Subunit-specific NMDA receptor trafficking to synapses. Neuron 35: 345–353, 2002.[CrossRef][Web of Science][Medline]

Bekkers JM and Stevens CF. Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc Natl Acad Sci USA 88: 7834–7838, 1991.[Abstract/Free Full Text]

Berberich S, Punnakkal P, Jensen V, Pawlak V, Seeburg PH, Hvalby O, and Kohr G. Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. J Neurosci 25: 6907–6910, 2005.[Abstract/Free Full Text]

Bolton MM, Blanpied TA, and Ehlers MD. Localization and stabilization of ionotropic glutamate receptors at synapses. Cell Mol Life Sci 57: 1517–1525, 2000.[CrossRef][Web of Science][Medline]

Chavis P and Westbrook G. Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse. Nature 411: 317–321, 2001.[CrossRef][Medline]

Cottrell JR, Dube GR, Egles C, and Liu G. Distribution, density, and clustering of functional glutamate receptors before and after synaptogenesis in hippocampal neurons. J Neurophysiol 84: 1573–1587, 2000.[Abstract/Free Full Text]

Flint AC, Maisch US, Weishaupt JH, Kriegstein AR, and Monyer H. NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex. J Neurosci 17: 2469–2476, 1997.[Abstract/Free Full Text]

Gottmann K, Mehrle A, Gisselmann G, and Hatt H. Presynaptic control of subunit composition of NMDA receptors mediating synaptic plasticity. J Neurosci 17: 2766–2774, 1997.[Abstract/Free Full Text]

Guillaud L, Setou M, and Hirokawa N. KIF17 dynamics and regulation of NR2B trafficking in hippocampal neurons. J Neurosci 23: 131–140, 2003.[Abstract/Free Full Text]

Hardingham GE, Fukunaga Y, and Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5: 405–414, 2002.[Web of Science][Medline]

Hatton CJ and Paoletti P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46: 261–274, 2005.[CrossRef][Web of Science][Medline]

Hoffmann H, Gremme T, Hatt H, and Gottmann K. Synaptic activity-dependent developmental regulation of NMDA receptor subunit expression in cultured neocortical neurons. J Neurochem 75: 1590–1599, 2000.[CrossRef][Web of Science][Medline]

Ito I, Kawakami R, Sakimura K, Mishina M, and Sugiyama H. Input-specific targeting of NMDA receptor subtypes at mouse hippocampal CA3 pyramidal neuron synapses. Neuropharmacology 39: 943–951, 2000.[CrossRef][Web of Science][Medline]

Jahr CE and Stevens CF. Glutamate activates multiple single channel conductances in hippocampal neurons. Nature 325: 522–525, 1987.[CrossRef][Medline]

Kew JN, Richards JG, Mutel V, and Kemp JA. Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J Neurosci 18: 1935–1943, 1998.[Abstract/Free Full Text]

Kew JN, Trube G, and Kemp JA. A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J Physiol 497: 761–772, 1996.[Abstract/Free Full Text]

Kim E and Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 5: 771–781, 2004.[CrossRef][Web of Science][Medline]

Kirson ED and Yaari Y. Synaptic NMDA receptors in developing mouse hippocampal neurones: functional properties and sensitivity to ifenprodil. J Physiol 497: 437–455, 1996.[Abstract/Free Full Text]

Lavezzari G, McCallum J, Dewey CM, and Roche KW. Subunit-specific regulation of NMDA receptor endocytosis. J Neurosci 24: 6383–6391, 2004.[Abstract/Free Full Text]

Li JH, Wang YH, Wolfe BB, Krueger KE, Corsi L, Stocca G, and Vicini S. Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons. Eur J Neurosci 10: 1704–1715, 1998.[CrossRef][Web of Science][Medline]

Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson YP, and Wang YT. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304: 1021–1024, 2004.[Abstract/Free Full Text]

Luo J, Wang Y, Yasuda RP, Dunah AW, and Wolfe BB. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 51: 79–86, 1997.[Abstract/Free Full Text]

Massey PV, Johnson BE, Moult PR, Auberson YP, Brown MW, Molnar E, Collingridge GL, and Bashir ZI. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci 24: 7821–7828, 2004.[Abstract/Free Full Text]

Mohrmann R, Hatt H, and Gottmann K. Developmental regulation of subunit composition of extrasynaptic NMDA receptors in neocortical neurones. Neuroreport 11: 1203–1208, 2000.[Web of Science][Medline]

Monyer H, Burnashev N, Laurie DJ, Sakmann B, and Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529–540, 1994.[CrossRef][Web of Science][Medline]

Perez-Otano I and Ehlers MD. Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals 13: 175–189, 2004.[CrossRef][Web of Science][Medline]

Pickard L, Noel J, Henley JM, Collingridge GL, and Molnar E. Developmental changes in synaptic AMPA and NMDA receptor distribution and AMPA receptor subunit composition in living hippocampal neurons. J Neurosci 20: 7922–7931, 2000.[Abstract/Free Full Text]

Prybylowski K, Fu Z, Losi G, Hawkins LM, Luo J, Chang K, Wenthold RJ, and Vicini S. Relationship between availability of NMDA receptor subunits and their expression at the synapse. J Neurosci 22: 8902–8910, 2002.[Abstract/Free Full Text]

Rosenmund C, Feltz A, and Westbrook GL. Synaptic NMDA receptor channels have a low open probability. J Neurosci 15: 2788–2795, 1995.[Abstract]

Sans N, Petralia RS, Wang YX, Blahos J II, Hell JW, and Wenthold RJ. A developmental change in NMDA receptor-associated proteins at hippocampal synapses. J Neurosci 20: 1260–1271, 2000.[Abstract/Free Full Text]

Scannevin RH and Huganir RL. Postsynaptic organization and regulation of excitatory synapses. Nat Rev Neurosci 1: 133–141, 2000.[CrossRef][Web of Science][Medline]

Sheng M, Cummings J, Roldan LA, Jan YN, and Jan LY. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144–147, 1994.[CrossRef][Medline]

Steigerwald F, Schulz TW, Schenker LT, Kennedy MB, Seeburg PH, and Kohr G. C-Terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors. J Neurosci 20: 4573–4581, 2000.[Abstract/Free Full Text]

Stocca G and Vicini S. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol 507: 13–24, 1998.[Abstract/Free Full Text]

Tovar KR, Sprouffske K, and Westbrook GL. Fast NMDA receptor-mediated synaptic currents in neurons from mice lacking the epsilon2 (NR2B) subunit. J Neurophysiol 83: 616–620, 2000.[Abstract/Free Full Text]

Tovar KR and Westbrook GL. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci 19: 4180–4188, 1999.[Abstract/Free Full Text]

Townsend M, Yoshii A, Mishina M, and Constantine-Paton M. Developmental loss of miniature N-methyl-D-aspartate receptor currents in NR2A knockout mice. Proc Natl Acad Sci USA 100: 1340–1345, 2003.[Abstract/Free Full Text]

Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, Wolfe BB, and Grayson DR. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J Neurophysiol 79: 555–566, 1998.[Abstract/Free Full Text]

Weitlauf C, Honse Y, Auberson YP, Mishina M, Lovinger DM, and Winder DG. Activation of NR2A-containing NMDA receptors is not obligatory for NMDA receptor-dependent long-term potentiation. J Neurosci 25: 8386–8390, 2005.[Abstract/Free Full Text]

Wenthold RJ, Prybylowski K, Standley S, Sans N, and Petralia RS. Trafficking of NMDA receptors. Annu Rev Pharmacol Toxicol 43: 335–358, 2003.[CrossRef][Web of Science][Medline]

Zhong J, Russell SL, Pritchett DB, Molinoff PB, and Williams K. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol Pharmacol 45: 846–853, 1994.[Abstract]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. I. Stanika, N. B. Pivovarova, C. A. Brantner, C. A. Watts, C. A. Winters, and S. B. Andrews
Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity
PNAS, June 16, 2009; 106(24): 9854 - 9859.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Zhang and J. S. Diamond
Subunit- and Pathway-Specific Localization of NMDA Receptors and Scaffolding Proteins at Ganglion Cell Synapses in Rat Retina
J. Neurosci., April 1, 2009; 29(13): 4274 - 4286.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. Leveille, F. El gaamouch, E. Gouix, M. Lecocq, D. Lobner, O. Nicole, and A. Buisson
Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors
FASEB J, December 1, 2008; 22(12): 4258 - 4271.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. C. Harney, D. E. Jane, and R. Anwyl
Extrasynaptic NR2D-Containing NMDARs Are Recruited to the Synapse during LTP of NMDAR-EPSCs
J. Neurosci., November 5, 2008; 28(45): 11685 - 11694.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Atasoy, M. Ertunc, K. L. Moulder, J. Blackwell, C. Chung, J. Su, and E. T. Kavalali
Spontaneous and Evoked Glutamate Release Activates Two Populations of NMDA Receptors with Limited Overlap
J. Neurosci., October 1, 2008; 28(40): 10151 - 10166.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. Sornarajah, O. C. Vasuta, L. Zhang, C. Sutton, B. Li, A. El-Husseini, and L. A. Raymond
NMDA Receptor Desensitization Regulated by Direct Binding to PDZ1-2 Domains of PSD-95
J Neurophysiol, June 1, 2008; 99(6): 3052 - 3062.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Zhao, Y. Peng, Z. Xu, R.-q. Chen, Q.-h. Gu, Z. Chen, and W. Lu
Synaptic Metaplasticity through NMDA Receptor Lateral Diffusion
J. Neurosci., March 19, 2008; 28(12): 3060 - 3070.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. Cline and K. Haas
The regulation of dendritic arbor development and plasticity by glutamatergic synaptic input: a review of the synaptotrophic hypothesis
J. Physiol., March 15, 2008; 586(6): 1509 - 1517.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
G. Gonzalez-Burgos, S. Kroener, A. V. Zaitsev, N. V. Povysheva, L. S. Krimer, G. Barrionuevo, and D. A. Lewis
Functional Maturation of Excitatory Synapses in Layer 3 Pyramidal Neurons during Postnatal Development of the Primate Prefrontal Cortex
Cereb Cortex, March 1, 2008; 18(3): 626 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. J. Brasier and D. E. Feldman
Synapse-Specific Expression of Functional Presynaptic NMDA Receptors in Rat Somatosensory Cortex
J. Neurosci., February 27, 2008; 28(9): 2199 - 2211.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. Z. Harris and D. L. Pettit
Recruiting Extrasynaptic NMDA Receptors Augments Synaptic Signaling
J Neurophysiol, February 1, 2008; 99(2): 524 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J.-P. Zhao and M. Constantine-Paton
NR2A / Mice Lack Long-Term Potentiation But Retain NMDA Receptor and L-Type Ca2+ Channel-Dependent Long-Term Depression in the Juvenile Superior Colliculus
J. Neurosci., December 12, 2007; 27(50): 13649 - 13654.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. J. Hall, B. Ripley, and A. Ghosh
NR2B Signaling Regulates the Development of Synaptic AMPA Receptor Current
J. Neurosci., December 5, 2007; 27(49): 13446 - 13456.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z. Yi, R. S. Petralia, Z. Fu, C. C. Swanwick, Y.-X. Wang, K. Prybylowski, N. Sans, S. Vicini, and R. J. Wenthold
The Role of the PDZ Protein GIPC in Regulating NMDA Receptor Trafficking
J. Neurosci., October 24, 2007; 27(43): 11663 - 11675.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. X. Soriano and G. E. Hardingham
Compartmentalized NMDA receptor signalling to survival and death
J. Physiol., October 15, 2007; 584(2): 381 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Z. Harris and D. L. Pettit
Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices
J. Physiol., October 15, 2007; 584(2): 509 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Groc, D. Choquet, F. A. Stephenson, D. Verrier, O. J. Manzoni, and P. Chavis
NMDA Receptor Surface Trafficking and Synaptic Subunit Composition Are Developmentally Regulated by the Extracellular Matrix Protein Reelin
J. Neurosci., September 19, 2007; 27(38): 10165 - 10175.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. A. Al-Hallaq, T. P. Conrads, T. D. Veenstra, and R. J. Wenthold
NMDA Di-Heteromeric Receptor Populations and Associated Proteins in Rat Hippocampus
J. Neurosci., August 1, 2007; 27(31): 8334 - 8343.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Liu, T. P. Wong, M. Aarts, A. Rooyakkers, L. Liu, T. W. Lai, D. C. Wu, J. Lu, M. Tymianski, A. M. Craig, et al.
NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo
J. Neurosci., March 14, 2007; 27(11): 2846 - 2857.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Huang, B. N. Kang, J. Tian, Y. Liu, H. R. Luo, L. Hester, and S. H. Snyder
The Cationic Amino Acid Transporters CAT1 and CAT3 Mediate NMDA Receptor Activation-Dependent Changes in Elaboration of Neuronal Processes via the Mammalian Target of Rapamycin mTOR Pathway
J. Neurosci., January 17, 2007; 27(3): 449 - 458.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Groc, M. Heine, S. L. Cousins, F. A. Stephenson, B. Lounis, L. Cognet, and D. Choquet
NMDA receptor surface mobility depends on NR2A-2B subunits
PNAS, December 5, 2006; 103(49): 18769 - 18774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. L. Hammond, C. Sims, K. Parameshwaran, V. Suppiramaniam, M. Schachner, and A. Dityatev
Neural Cell Adhesion Molecule-associated Polysialic Acid Inhibits NR2B-containing N-Methyl-D-aspartate Receptors and Prevents Glutamate-induced Cell Death
J. Biol. Chem., November 17, 2006; 281(46): 34859 - 34869.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. Lu, Z. Fu, I. Karavanov, R. P. Yasuda, B. B. Wolfe, A. Buonanno, and S. Vicini
NMDA Receptor Subtypes at Autaptic Synapses of Cerebellar Granule Neurons
J Neurophysiol, November 1, 2006; 96(5): 2282 - 2294.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. B. Alex, A. J. Baucum, and K. S. Wilcox
Effect of Conantokin G on NMDA Receptor-Mediated Spontaneous EPSCs in Cultured Cortical Neurons
J Neurophysiol, September 1, 2006; 96(3): 1084 - 1092.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Izumi, Y. P. Auberson, and C. F. Zorumski
Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors.
J. Neurosci., July 5, 2006; 26(27): 7181 - 7188.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Ivanov, C. Pellegrino, S. Rama, I. Dumalska, Y. Salyha, Y. Ben-Ari, and I. Medina
Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons
J. Physiol., May 1, 2006; 572(3): 789 - 798.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/3/1727    most recent
00771.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, C. G.
Right arrow Articles by Westbrook, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, C. G.
Right arrow Articles by Westbrook, G. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the The American Physiological Society.